WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, ...
Revvity, Inc. RVTY recently collaborated with Element Biosciences, Inc. The tie-up is aimed at introducing workflow solutions that can save the time and effort needed for the genomic analysis of ...
Combination of Revvity’s proprietary Pin-point platform and Profluent’s AI-engineered proteins created to inspire accelerated development of novel gene editing therapies This new Pin-point ...
WALTHAM, Mass.--(BUSINESS WIRE)--#LifeSciences--Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results